Asia-Pacific South Korea Intellectual Property

Bae, Kim & Lee LLC is a full-service law firm with the capability to advise on prosecution, transactional matters and litigation in respect of all IP assets. The team serves a diverse range of clients, including manufacturers of luxury brands, entertainment groups, pharmaceutical conglomerates and technology developers. Its key clients include Netflix, Walt Disney Korea, Uber Technologies and Starbucks Korea. The firm is frequently sought out for investigations and compliance involving trade secrets, in both civil and criminal actions and is also able to advise on data protection and privacy matters.

Kim & Chang's intellectual property group is market-leading and regularly acts for well-known multinational corporations in high-value litigation before all levels of court. The team handles the full gamut of contentious IP work, including patent, trade mark and copyright disputes. Kim & Chang houses a substantial group of foreign lawyers who provide analysis on overseas matters and are licensed to practise in a variety of key jurisdictions. It offers a high level of technical expertise with a substantial number of IP lawyers alongside a sizeable group of patent scientists and support members. The law firm also offers full patent prosecution services. Key clients include Apple, Tencent, Samsung Display and L'Oréal.

Lee & Ko fields a top-flight group of intellectual property lawyers with outstanding dispute resolution skills, representing market-leading technology and software companies. The practice also has a substantial group of patent attorneys to advise on IP prosecution matters, with considerable knowledge in the technology and pharmaceuticals areas. It frequently advises clients across a range of industries from pharmaceuticals and chemicals to IT and consumer goods, taking on trade mark, trade secret and copyright mandates. The team's notable clients include Novartis International, SKC Kolon PI, Samsung Bioepis and KBS.

Shin & Kim fields a respected team that handles contentious and transactional matters, offering extensive technical expertise in areas such as electronics, pharmaceuticals, telecommunications and software development. The team possesses notable experience serving clients on domestic and cross-border patent, copyright and trade mark matters, as well as trade secret issues. It also assists with availability searches as well as IP due diligence in connection with transactions and licensing agreements. The practice demonstrates expertise in cutting-edge IP areas such as copyrighting of games, cyber-squatting and content streaming.

Yulchon is home to a range of legal talent and is especially well regarded for its robust handling of contentious matters as well as non-contentious issues. The team attracts top-flight domestic and international clients in the pharmaceutical, electronics, fashion and entertainment areas, drawing on its collective technical knowledge. It comprises highly experienced IP practitioners, patent attorneys and former patent judges. The firm is recognised for its handling of patent, trade mark and trade secrets matters. Its key clients include Hanwha Group, Corning and Seoul Semiconductor.

Yoon & Yang has a well-rounded practice recommended for its litigation abilities, especially in the IT and pharmaceutical sectors. The team services a domestic and multinational client base in respect of patent, trade mark and copyright infringement disputes. It is frequently instructed on cross-border IP litigation and also experienced in handling cases involving issues of competition law. Its current client roster includes SK Innovation, SK bioscience, Hyundai Mobis and Dyson Technology. The practice handles mandates concerning trade secrets misappropriation and data protection.

Jipyong houses a team of specialists handling various contentious IP mandates. The practice possesses expertise advising on trade mark, copyright and patent infringements. It works with private corporations and government agencies. The practice's key clients include Kakao, Dongkook Pharmaceutical and Korea Communications Commission.